title: 11C-Acetate PET/CT Monitoring Therapy of Multiple Myeloma.
abstract: A 67-year-old man with newly diagnosed multiple myeloma underwent both FDG and C-acetate PET/CT sequentially on different days. There was increased FDG activity only in L1 vertebral body, but there was diffuse abnormal C-acetate activity throughout the skeletal system. After the successful therapy, the patient who was on remission clinically underwent follow-up PET/CT scans. Interestingly, L1 remained to have elevated FDG, although with less intensity. In contrast, there was no abnormal C-acetate activity anywhere in the body. The patient remained in remission clinically.
authors.affiliation: From the Department of Nuclear Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Science & Peking Union Medical College, Beijing, China.
authors.forename: Wenjia
authors.initials: W
authors.lastname: Zhu
authors.forename: Yonghong
authors.initials: Y
authors.lastname: Dang
authors.forename: Yanru
authors.initials: Y
authors.lastname: Ma
authors.forename: Fang
authors.initials: F
authors.lastname: Li
authors.forename: Li
authors.initials: L
authors.lastname: Huo
mesh_terms: D000085:Acetates; D002244:Carbon; D006801:Humans; D008297:Male; D009101:Multiple Myeloma / Q000000981:diagnostic imaging* / Q000628:therapy*; D000072078:Positron Emission Tomography Computed Tomography; D016896:Treatment Outcome
chemical_list: D000085:Acetates; C438206:carbon-11 acetate; D002244:Carbon